Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study
Year: 2024
Type: article
Study design: Observational Study
Abstract: The PEGASUS study is the first multicentric and prospective assessment of the safety of air travel flying in pulmonary hypertension (PH) (NCT03051763). Data of air travel from 60 patients with PH was available. No severe adverse events occurred. Nine patients self-reported mild adverse events during flight (13%), while after landing, 12 patients reported events (20%). Solely one patient (2%) had an adverse event leading to medical consultation. In patients with PH and World Health Organization functional classes II and III, air travel was safe.
Source: Pulmonary Circulation
DOI: 10.1002/pul2.12397
Authors: Athiththan Yogeswaran, Jan Grimminger, Khodr Tello, Lukas Becker, Werner Seeger, Friedrich Grimminger, Natascha Sommer, Hossein A. Ghofrani, Tobias J. Lange, Stefan Stadler, Karen Olsson, Jan C. Kamp, Stephan Rosenkranz, Felix Gerhardt, Katrin Milger, Michaela Barnikel, Silvia Ulrich, Stéphanie Saxer, Ekkehard Grünig, Satenik Harutynova, Christian Opitz, Hans Klose, Heinrike Wilkens, Michael Halank, Melanie Heberling, Henning Gall, Manuel J. Richter
Institutions: Justus-Liebig-Universität Gießen, German Center for Lung Research, Universities of Giessen and Marburg Lung Center, Cardio-Pulmonary Institute, Klinik Bad Reichenhall, University of Regensburg, University Hospital Regensburg, Medizinische Hochschule Hannover, University of Cologne, LMU Klinikum, Ludwig-Maximilians-Universität München, University Hospital Zurich, DRK Kliniken Berlin, University Medical Center Hamburg-Eppendorf, Universitätsklinikum des Saarlandes, University Hospital Carl Gustav Carus, Technische Universität Dresden
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,310
Funders: National Science Foundation, Eli Lilly and Company, Pfizer, AstraZeneca, United Therapeutics Corporation, Acceleron, Bayer HealthCare, Deutsche Forschungsgemeinschaft, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Medizinischen Hochschule Hannover, EMDO Stiftung, Lungenliga Schweiz, Daiichi Sankyo Europe, Cilag
Awards: G802506612, G8949905862
OpenAlex ID: W4401340669
